Gender Female
Dr. Powell has over 15 years of experience in the pharmaceutical industry including assignments at McKinsey, Eli Lilly and GlaxoSmithKline. She currently is serving as CEO of TARGET PharmaSolutions, a clinical data solutions company that specializes in acquiring, analyzing, and disseminating data in the post-marketing environment.
At
Medgility, a consulting company focused on Strategy and Business Development for Emerging Companies, she has worked with multiple start-up companies. Most notably, she recently served as interim Vice President of Corporate Development for Aerial BioPharma where she led the asset sale of ADX-N05 to Jazz Pharmaceutical which resulted in a >$500M transaction.
Before forming Medgility, Dr. Powell was the Vice President of the US Transformation Office for GlaxoSmithKline. In addition to this role, Dr. Powell has held various positions in sales and marketing for US and Global development programs at all stages – from Phase 1 to post patent expiry. Dr. Powell received her Doctorate of Pharmacy degree from the University of North Carolina- Chapel Hill where she was a Hollingsworth Scholar. She also received a Masters of Business Administration from Stanford University.
